Home » Stocks » FLGT

Fulgent Genetics, Inc. (FLGT)

Stock Price: $74.64 USD 1.63 (2.23%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $74.40 -0.24 (-0.32%) May 7, 6:51 PM
Market Cap 2.16B
Revenue (ttm) 421.71M
Net Income (ttm) 214.31M
Shares Out 22.69M
EPS (ttm) 15.82
PE Ratio 4.72
Forward PE 5.88
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $74.64
Previous Close $73.01
Change ($) 1.63
Change (%) 2.23%
Day's Open 73.72
Day's Range 73.19 - 77.40
Day's Volume 2,502,713
52-Week Range 13.40 - 189.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

More than 4,500% revenue growth gave Wall Street and shareholders something to cheer about.

2 days ago - The Motley Fool

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 10.02% and 13.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 days ago - Zacks Investment Research

FULGENT GENETIC (FLGT) closed the most recent trading day at $73.01, moving +1.61% from the previous trading session.

3 days ago - Zacks Investment Research

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing large-scale COVID-19 testing services and comprehensive testing s...

3 days ago - Business Wire

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its sc...

3 days ago - Business Wire

Good news for the U.S. has been bad news for shareholders.

4 days ago - The Motley Fool

COVID-19 testing and NGS-based testing solutions are expected to have contributed to Fulgent Genetics' (FLGT) Q1 earnings.

1 week ago - Zacks Investment Research

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

FULGENT GENETIC (FLGT) closed at $87.64 in the latest trading session, marking a +0.52% move from the prior day.

1 week ago - Zacks Investment Research

The genetic testing giant's journey resembles the path of past winners.

1 week ago - The Motley Fool

The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.

Other stocks mentioned: ILMN, TXG
2 weeks ago - The Motley Fool

FULGENT GENETIC (FLGT) closed at $86.78 in the latest trading session, marking a -0.99% move from the prior day.

2 weeks ago - Zacks Investment Research

If you are screening the market for high-return investments, you may want to consider the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt (Trades, Por...

Other stocks mentioned: ENIA, VIVO
2 weeks ago - GuruFocus

Less COVID-19 testing means less revenue for some companies.

Other stocks mentioned: ABT, BDX, QDEL
2 weeks ago - The Motley Fool

Be wary of companies posting abnormal growth rates.

Other stocks mentioned: COIN
2 weeks ago - The Motley Fool

He also gave clues that point to a few possible targets.

2 weeks ago - The Motley Fool

If you want to enhance your likelihood to beat the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other stocks mentioned: BDSI, BPMC
2 weeks ago - GuruFocus

Growth last year was awesome, but there is something to be even more excited about.

3 weeks ago - The Motley Fool

TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions throug...

3 weeks ago - GlobeNewsWire

In the latest trading session, FULGENT GENETIC (FLGT) closed at $88.95, marking a +1.37% move from the previous day.

3 weeks ago - Zacks Investment Research

They've underperformed the S&P 500 in the past month, but these stocks show lots of potential over the long term.

Other stocks mentioned: VIA
3 weeks ago - The Motley Fool

Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here's what investors need to know now.

1 month ago - InvestorPlace

FULGENT GENETIC (FLGT) closed at $85.24 in the latest trading session, marking a -0.42% move from the prior day.

1 month ago - Zacks Investment Research

A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...

Other stocks mentioned: AMRS, DCP, EXPI, FUTU, MIK, SI, SPWR
1 month ago - InvestorPlace

Industry trends could support massive gains for shareholders over the next 10 years.

Other stocks mentioned: NARI, TDOC
1 month ago - The Motley Fool

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

Other stocks mentioned: ABT, BDX, BIO, DGX, IDXX
1 month ago - Zacks Investment Research

Shareholders could be big winners if the demand for COVID-19 testing lingers.

1 month ago - The Motley Fool

Investors seeking a multi-year growth opportunity should watch out for these three stocks.

Other stocks mentioned: DDOG, SQ
1 month ago - The Motley Fool

Is (FLGT) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

Gene science will continue to drive the healthcare sector to new heights.

Other stocks mentioned: BNGO, ILMN
1 month ago - The Motley Fool

If you are following the crowd, you might miss these disruptive companies.

Other stocks mentioned: NARI
1 month ago - The Motley Fool

This coronavirus testing company has been booming, but is its hot streak about to end?

1 month ago - The Motley Fool

One group especially stands out.

1 month ago - The Motley Fool

Agreement leverages Fulgent's Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing research of SARS-CoV-2, the virus that causes COVID-19 Agreement leverages Fulgent'...

1 month ago - GlobeNewsWire

Despite tremendous growth, the stock is cheap based on at least one common Wall Street metric.

1 month ago - The Motley Fool

These two genetic testing companies have different approaches.

Other stocks mentioned: NVTA
1 month ago - The Motley Fool

Is (FLGT) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

2020 was a wild run for the biotech sector, with COVID-19 dominating the headlines. What will happen this year?

Other stocks mentioned: CODX, JNJ, MRNA, NVAX
1 month ago - The Motley Fool

Thanks to a blowout fourth quarter, a Los Angeles-area diagnostic and genetics company saw its shares soar to an all-time high. Fulgent Genetics Inc.(NASDAQ:FLGT) hit nearly $190 during the first week o...

1 month ago - GuruFocus

Amkor Technology (AMKR), Daqo New Energy (DQ) and Fulgent Genetics (FLGT) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Other stocks mentioned: AMKR, DQ
2 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

2 months ago - Zacks Investment Research

New COVID-19 tests catapulted this company to fame, but investors are worried about what happens next.

2 months ago - The Motley Fool

Investors loved the company's fourth-quarter update but are concerned the growth could stall.

2 months ago - The Motley Fool

Fulgent Genetics (FLGT) stock is on the rise in pre-market trading and we know exactly why investors are so happy with the company. The post FLGT Stock: 3 Reasons Why Fulgent Genetics Is Soaring Today a...

2 months ago - InvestorPlace

TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions throug...

2 months ago - GlobeNewsWire

The genetic-testing company is firing on all cylinders.

2 months ago - The Motley Fool

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 40.59% and 30.77%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Strong earnings sent both of these healthcare stocks higher after hours on Thursday.

Other stocks mentioned: TTOO
2 months ago - The Motley Fool

Shares of Fulgent Genetics (NASDAQ:FLGT) moved higher by 24.0% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 15400.00% year over year to $6....

2 months ago - Benzinga

Fourth Quarter 2020 Results:

2 months ago - GlobeNewsWire

About FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Sep 29, 2016
CEO
Ming Hsieh
Employees
480
Stock Exchange
NASDAQ
Ticker Symbol
FLGT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for FLGT stock is "Buy." The 12-month stock price forecast is 89.00, which is an increase of 19.24% from the latest price.

Price Target
$89.00
(19.24% upside)
Analyst Consensus: Buy